Denosumab Significantly Increases DXA BMD at Both Trabecular and Cortical Sites: Results From the FREEDOM Study

Michael A. Bolognese, Christence Stubbe Teglbjærg, Jose R. Zanchetta, Kurt Lippuner, Michael R. McClung, Maria Luisa Brandi, Arne Høiseth, Péter Lakatos, Alfred H. Moffett, Roman S. Lorenc, Andrea Wang, Cesar Libanati

April 20 2012

Michael A. Bolognese1, Christence Stubbe Teglbjærg2, Jose R. Zanchetta3, Kurt Lippuner4, Michael R. McClung5, Maria Luisa Brandi6, Arne Høiseth7, Péter Lakatos8, Alfred H. Moffett9, Roman S. Lorenc10, Andrea Wang11, Cesar Libanati12

1 The Bethesda Health Research Center, Bethesda, MD, USA
2 Center for Clinical and Basic Research, Ballerup, Denmark
3 Instituto de Investigaciones Metab olicas, Buenos Aires, Argentina 
4 Osteoporosis Policlinic, University Hospital University of Berne, Berne, Switzerland
5 Oregon Osteoporosis Center, Portland, OR, USA
6 Department of Internal Medicine, University of Florence, Florence, Italy
7 Curato Røntgeninstitutt, Oslo, Norway
8 1st Department of Medicine, Semmelweis University, Budapest, Hungary 
9 OB-GYN Associates of Mid Florida, Leesburg, FL, USA 
10 Department of Biochemistry and Experimental Medicine, The Children’s Health Institute, Warsaw, Poland 
11 Global Biostatistics Department, Amgen Inc., Thousand Oaks, CA, USA 
12 Global Clinical Development Department, Amgen Inc., Thousand Oaks, CA, USA


Aging clinical and experimental research offers a multidisciplinary forum on the progressing field of gerontology and geriatrics. The areas covered by the journal include: biogerontology, neurosciences, epidemiology, clinical gerontology and geriatric assessment, social, economical and behavioral gerontology. “Aging clinical and experimental research” appears bimonthly and publishes review articles, original papers and case reports.

Discover the official journal of ESCEO on and read the journal contents on
You can get the table of contents of every new issue published in Aging Clinical and Experimental Research. Sign up for the ToC Alert for this journal with your e-mail address. It’s easy and it’s free.